𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives

✍ Scribed by OLLE RINGDÉN; KATARINA LE BLANC

Book ID
109343438
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
126 KB
Volume
113
Category
Article
ISSN
0365-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allogeneic hematopoietic stem cell trans
Allogeneic hematopoietic stem cell transplantation in ovarian cancer—the EBMT experience
✍ Jacques-Olivier Bay; Aurélie Cabrespine-Faugeras; Reza Tabrizi; Didier Blaise; P 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 244 KB

## Abstract Although preliminary results suggest that allogeneic hematopoietic stem cell transplantation (allo HCT) for ovarian cancer (OC) is a feasible procedure, the low patient number in previous studies had limited ability to evaluate the true benefit of allo HCT in OC. This retrospective mult

Monitoring of WT1-specific cytotoxic T l
Monitoring of WT1-specific cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation
✍ Yuriko Morita; Yuji Heike; Mami Kawakami; Osamu Miura; Shin-ichi Nakatsuka; Mich 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 791 KB

## Abstract Donor‐derived cytotoxic T lymphocytes (CTL) that respond to tumor antigens emerge after hematopoietic stem cell transplantation (HSCT), particularly in association with the status of immune recovery. To analyze the frequency of CTL against PR1, PRAME and WT1 after HSCT, a tetramer‐based

Predictors of prolonged survival after a
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
✍ Qaiser Bashir; Hassan Khan; Robert Z. Orlowski; Ali Imran Amjad; Nina Shah; Simr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 746 KB

## Abstract A total of 149 patients with multiple myeloma (MM) who received allogeneic hematopoietic stem cell transplantation (allo‐HCT) with myeloablative (MAC; __n__ = 38) or reduced‐intensity conditioning (RIC; __n__ = 110) regimens at MD Anderson Cancer Center were evaluated. Of the total, 120